Restoring migraine sufferers' ability to function normally: A comparison of rizatriptan and other triptans in randomized trials

European Neurology

Volumn 48, Issue 3, 2002, Pages 172-177

  Bussone, Gennaro ^a   D'Amico, Domenico ^a   McCarroll, Kathleen A ^b   Gerth, William ^b   Lines, Christopher R ^b  

^a DEPARTMENT OF NEUROSURGERY   (Italy)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

5 HT1B 1D receptor agonists; Migraine; Naratriptan; Rizatriptan; Sumatriptan; Triptans; Zolmitriptan

Indexed keywords

NARATRIPTAN; RIZATRIPTAN; SUMATRIPTAN; ZOLMITRIPTAN;

ADOLESCENT; ADULT; AGED; ARTICLE; BED REST; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DISABILITY; DISEASE SEVERITY; EVALUATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; MIGRAINE; PRIORITY JOURNAL; RANDOMIZATION; RETROSPECTIVE STUDY; RISK;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; AGED; FEMALE; HUMANS; INDOLES; MALE; MIDDLE AGED; MIGRAINE DISORDERS; OXAZOLIDINONES; PIPERIDINES; RANDOMIZED CONTROLLED TRIALS; RETROSPECTIVE STUDIES; SEROTONIN AGONISTS; SUMATRIPTAN; TREATMENT OUTCOME; TRIAZOLES; TRYPTAMINES;

EID: 0036419886     PISSN: 00143022     EISSN: None     Source Type: Journal    
DOI: 10.1159/000065513     Document Type: Article

References (19)

1. Staffa JA, Lipton RB, Stewart WF: The epidemiology of migraine headache. Rev Contemp Pharmacol 1994;5:241-252.
2. Stewart WF, Shechter A, Rasmussen BK: Migraine prevalence: A review of population-based studies. Neurology 1994;44(suppl 4):S17-S23.
3. Lipton RB, Stewart WF: Migraine in the United States: A review of epidemiology and healthcare use. Neurology 1993;43(suppl 3):S6-S10.
4. Hu XH, Markson LE, Lipton RB, Stewart WF, Berger ML: Burden of migraine in the United States. Arch Intern Med 1999;159:813-818.
5. Menken M, Munsat TL, Toole JF: The global burden of disease study: Implications for neurology. Arch Neurol 2000;57:418-420.
6. Tfelt-Hansen P, Teall J, Rodriguez F, Giacovazzo M, Paz J, Malbecq W, Block GA, Reines SA, Visser WH: Oral rizatriptan versus oral sumatriptan: A direct comparative study in the acute treatment of migraine. Headache 1998;38:748-755.
7. Goldstein J, Ryan R, Jiang K, Getson A, Norman B, Block GA, Lines C: Crossover comparison of rizatriptan 5 mg and 10 mg versus sumatriptan 25 and 50 mg in migraine. Rizatriptan Protocol 046 Study Group. Headache 1998;38: 737-747.
8. Pascual J, Vega P, Diener HC, Allen C, Vrijens F, Patel K: Comparison of rizatriptan 10 mg versus zolmitriptan 2.5 mg in the acute treatment of migraine. Rizatriptan-Zolmitriptan Study Group. Cephalalgia 2000;20:455-461.
9. Bomhof M, Paz J, Legg N, Allen C, Vandormael K, Patel K: Comparison of rizatriptan 10 mg vs. naratriptan 2.5 mg in migraine. Eur Neurol 1999;42:173-179.
10. Visser WH, Terwindt GM, Reines SA, Jiang K, Lines CR, Ferrari M: Rizatriptan vs sumatriptan in the acute treatment of migraine. Arch Neurol 1996;53:1132-1137.
11. Fuseau E, Petricoul O, Sabin A, Pereira A, O'Quinn S, Thein S, Leibowitz M, Purdon H, McNeal S, Salonen R, Metz A, Coates P: Effect of encapsulation on absorption of sumatriptan tablets: Data from healthy volunteers and patients during a migraine. Clin Ther 2001;23:242-251.
12. Headache Classification Committee of the International Headache Society: Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988;8(Suppl 7):1-96.
13. International Headache Society Clinical Trials Subcommittee: Guidelines for controlled trials of drugs in migraine: Second edition. Cephalalgia 2000;20:765-786.
14. Jones B, Kenward MG: Design and Analysis of Cross-over Trials. Monographs on Statistics and Applied Probability. New York, Chapman and Hall, 1989.
15. Senn S: Crossover designs; in Armitage P, Colton T (eds): Encyclopedia of Biostatistics. New York, Wiley, 1998, vol 2, pp 1033-1049.
16. Adelman JU, Lipton RB, Ferrari MD, Diener H-C, McCarroll KA, Vandormael K, Lines CR: Comparison of rizatriptan and other triptans on stringent measures of efficacy. Neurology 2001;57:1377-1383.
17. Gerth WC, Mannix L, McCarroll KA, Vandormael K, Zhang Q, Santanello NC: Patient satisfaction with rizatriptan 10 mg vs. other triptans: Head-to-head comparisons. Headache 2000;40:408-409.
18. Ferrari MD: Migraine. Lancet 1998;351:1043-1051.
19. Holmes WF, MacGregor A, Sawyer JPC, Lipton RB: Information about migraine disability influences physicians' perception of illness severity and treatment needs. Headache 2000;41:343-350.